Lexicon Pharmaceuticals, Inc./De - Additional Proxy Soliciting Materials (definitive) (DEFA14A)
March 14 2008 - 4:12PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC. 20549
SCHEDULE
14A
(Rule
14A-101)
INFORMATION
REQUIRED IN PROXY STATEMENT
SCHEDULE
14A INFORMATION
Proxy
Statement Pursuant to Section 14(a) of
the
Securities Exchange Act of 1934
Filed by the Registrant
x
Filed by a Party other than the Registrant
Check the
appropriate box:
o
|
|
Preliminary Proxy Statement
|
o
|
|
Confidential, for Use of the
Commission Only
|
o
|
|
Definitive Proxy Statement
|
|
|
(as
permitted by Rule 14a-6(e)(2))
|
x
|
|
Definitive Additional
Materials
|
|
|
|
o
|
|
Soliciting Material Pursuant to
Rule 14a-11(c)
or Rule 14a-12
|
|
|
|
LEXICON
PHARMACEUTICALS, INC.
|
(Name
of
Registrant
as Specified In Its
Charter)
|
|
(Name of
Person(s) Filing Proxy Statement, if Other Than the
Registrant)
|
Payment of
Filing Fee (Check the appropriate box):
o
|
Fee
computed
on
table below per Exchange Act
Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title
of each class of securities to which transaction
applies: N/A
|
|
(2)
|
Aggregate
number of securities to which transaction
applies: N/A
|
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
calculated and state how it was
determined): N/A
|
|
(4)
|
Proposed
maximum aggregate value of transaction: N/A
|
|
(5)
|
Total
fee paid: $0
|
o
|
Fee paid previously with
preliminary materials: N/A
|
o
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
(1)
|
Amount
Previously Paid:
|
|
(2)
|
Form, Schedule or
Registration Statement No.:
|
|
(3)
|
Filing
Party:
|
|
(4)
|
Date
Filed
|
Important
Notice Regarding the Availability of Proxy Materials for the Stockholder
Meeting to be held on 4/23/08
|
This
communication presents only an overview of the more complete proxy materials
that are available to you on the Internet. We encourage you to access and review
all of the important information contained in the proxy materials before
voting.
The
following materials are available for view:
Notice
and Proxy Statement / Annual Report
To view
this material, have the 12-digit Control #(s) available and visit:
www.proxyvote.com
If
you want to receive a paper or e-mail copy of the above listed documents you
must request one. There is no charge to you for requesting a copy.
To
facilitate timely delivery please make the request as instructed below on or
before 4/9/08.
To
request material:
|
Internet:
www.proxyvote.com
|
Telephone:
1-800-579-1639
|
**Email:
sendmaterial@proxyvote.com
|
**If
requesting material by e-mail please send a blank e-mail with the
12-digit Control# (located on the
following page)
in the subject line. Requests, instructions and other
inquiries will NOT be forwarded to your investment advisor.
|
|
LEXICON
PHARMACEUTICALS, INC.
|
|
|
|
|
|
Vote In Person
|
|
LEXICON
PHARMACEUT
ICALS,
INC.
8800 TECHNOLOGY FOREST PLACE
THE WOODLANDS, TX 77381-4287
|
|
Many stockholder meetings have attendance requirements
including, but not limited to, the possession of an attendance
ticket issued by the entity holding the meeting. Please check the
meeting materials for any special requirements for meeting
attendance. At the Meeting you will need to request a ballot to vote
these shares.
|
|
|
|
|
|
Vote By Internet
|
|
|
|
To
vote now by Internet, go to
WWW.PROXYVOTE.COM
. Use the Internet to
transmit your voting instructions and for electronic delivery of
information up until 11:59 P.M. Eastern Time the day before the cut-off
date or meeting date. Have your notice in hand when you access the web
site and follow the
instructions.
|
Meeting Location
The
Annual Meeting for holders as of 2/26/08 is to be held on 4/23/08 at 1:30 p.m.
Central at:
The
Woodlands Waterway Marriot Hotel and Convention Center
1601 Lake
Robbins Drive
The
Woodlands, TX 77380
For
meeting directions, please call: 281-863-3503
THE
BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” ITEMS 1 AND
2.
1.
|
ELECTION
OF CLASS II DIRECTORS
|
Nominees:
|
01)
|
Samuel
L. Barker, Ph.D.
|
|
02)
|
Christopher
J. Sobecki
|
|
03)
|
Judith
L. Swain, M.D.
|
2. Ratification
and approval of the appointment of Ernst & Young LLP as the Company's
independent auditors for the fiscal year ending December 31, 2008.
3. In
their discretion, upon such other matters that may properly come before the
meeting or any adjournment or adjournments thereof.
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jul 2023 to Jul 2024